🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

20 recruiting trials

for Tricuspid Regurgitation (TR)

3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and Clinical Outcomes in Patients With Cardiac Implantable Electronic Device NCT07793916n/a1 site📍 Seoul Samsung Medical Center · Tests: 3D Transthoracic echocardiographic evaluation Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS) NCT06212193NA12 sites📍 Thousand Oaks📍 Detroit📍 Rochester Innoventric LTD · Tests: Trillium™ Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation NCT07140562NA1 site📍 Asunción Tangent Cardiovascular Inc. · Tests: Tricuspid Annular Therapy System Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial) NCT07454980NA7 sites📍 Naples📍 The Bronx📍 Vancouver Jenscare Innovation Inc. · Tests: TTVI with LuX-Valve Plus System, TTVI with EVOQUE Robotic Transjugular Transcatheter Tricuspid Valve Replacement NCT07516145NA1 site📍 Shatin Prince of Wales Hospital, Shatin, Hong Kong · Tests: Transcatheter tricuspid valve replacement EFS of the DUO System for Tricuspid Regurgitation NCT05913908NA18 sites📍 Phoenix📍 Thousand Oaks📍 Atlanta CroiValve Limited · Tests: DUO Transcatheter Tricuspid Coaptation Valve System Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement NCT06814574n/a1 site📍 München Deutsches Herzzentrum Muenchen A Post-Market Assessment of the Safety and Performance of the TriClip™ System NCT07586995n/a9 sites📍 Phoenix📍 La Jolla📍 Chicago Abbott Medical Devices · Tests: Tricuspid Transcatheter Edge-to-Edge Repair (TEER) TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System NCT07334691NA1 site📍 Bonn Cardiovalve Ltd. · Tests: Cardiovalve TR valve replacement System TriClip Japan Post-Approval Study NCT07509658n/a1 site📍 Suita Abbott Medical Devices · Tests: The TriClip System The TRICURE US IDE Pivotal Study NCT07528326NA1 site📍 Atlanta TRiCares · Tests: TRiCares Topaz TTVR System, Edwards EVOQUE TTVR System, TRiCares Topaz TTVR System Efficacy of Early Rhythm Control in AF With TR Patients NCT07607093n/a1 site📍 Seoul Samsung Medical Center · Tests: Anti-arrhythmic drugs for rhythm control, DC cardioversion, catheter ablation for rhythm control, Usual care Prospective Study of Lead-associated Tricuspid Regurgitation in Patients Undergoing New Transvalvular Lead Insertion NCT07342036n/a1 site📍 Bad Oeynhausen Hazem Omran First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation NCT07536724NA2 sites📍 Tashkent📍 Tashkent Medira GmbH · Tests: TRICENTOG2 Transcatheter Valve System for Tricuspid Regurgitation (TRICENTOG2 TVSTR) Natural History of Atrial Fibrillation-Induced Tricuspid Valve Remodeling in the Absence of Significant Tricuspid Regurgitation: A Three-Dimensional Echocardiographic Study NCT07617974n/a1 site📍 Milan Centro Cardiologico Monzino TTVR STRONG Under Coverage With Evidence Development (CED) Study NCT06833476n/a1 site📍 Irvine Edwards Lifesciences · Tests: EVOQUE DELINEATE-Prospective NCT07197736n/a1 site📍 New York Columbia University Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment NCT06877520NA3 sites📍 Tbilisi📍 Tbilisi📍 Tbilisi Tau-MEDICAL Co., Ltd. · Tests: Pivot Extend Tricuspid Regurgitation Spacer Device CT Prediction for Transcatheter Tricuspid Interventions NCT06951126n/a1 site📍 Bad Oeynhausen Heart and Diabetes Center North-Rhine Westfalia Annuloplasty for Not-Severe TR in Patients Undergoing MV Repair Versus Mitral Repair Only (NOSTRUM) NCT02996552NA3 sites📍 Rozzano📍 Milan📍 Warsaw Ospedale San Raffaele · Tests: M & T Repair Group, Mitral-Only Group
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy